Industrial Development Administration, Ministry of Economic Affairs
High-Value Pharmaceuticals Development & New-Process Technology Expansion Program
高值藥品發展與新製程技術拓展計畫
Subsidy ceilingUp to NT$1.5M (~NT$1,500,000)
Industry chapter12 · Consumer Goods & Chemical Industries
Eligibility
ROC-registered companies in good credit standing that hold a Taiwanese PIC/S GMP-certified manufacturing site or contract production to a PIC/S GMP-licensed Taiwan manufacturer.
What’s offered
Two tracks: technology counseling that helps producers develop new drug-product lines including pilot scale-up feasibility, and regulatory counseling that walks new dosage forms through the registration pathway.
Key terms
- Technology track — focus
- Accelerates new dosage-form high-value pharmaceutical development; funding capped at NT$1,000,000 per case.
- Regulatory track — focus
- High-value API 505(b)(2) submissions, public-citizen guidance and clinical-trial counseling — up to NT$1,500,000 plus NT$100,000 supplemental.
Application process
- 1Submit application
- 2Document review
- 3Vendor selection
- 4Notify result
- 5Begin counseling
Program structure
Technology counseling
- Review items — Product strategy, R&D timeline, financial assessment, quality assessment.
- Focus — Accelerate new-dosage-form high-value pharmaceutical development.
- Funding — Up to NT$1,000,000 per case.
Regulatory counseling
- Review items — Research strategy, R&D timeline, market assessment, financial assessment, quality assessment.
- Focus — High-value API 505(b)(2) new-dosage-form clinical-trial guidance — combination drug-device new formulations.
- Funding — Up to NT$1,500,000 plus NT$100,000 supplemental.
Application window
Per official announcement each cycle.
Who to contact
Pharmaceutical Industry Technology and Development Center (PITDC)
財團法人醫藥工業技術發展中心
Mr. Liu (劉先生)
English-language application support: not confirmed. Plan to bring a Mandarin-fluent collaborator to the first conversation.